Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001493152-24-007061
Filing Date
2024-02-20
Accepted
2024-02-16 18:37:07
Documents
4
Effectiveness Date
2024-02-20

Document Format Files

Seq Description Document Type Size
1 forms-8.htm S-8 107824
2 ex5-1.htm EX-5.1 9718
3 ex23-1.htm EX-23.1 3729
4 ex107.htm EX-FILING FEES 8616
  Complete submission text file 0001493152-24-007061.txt   130951
Mailing Address 10573 W. PICO BLVD. #58 LOS ANGELES CA 90064
Business Address 11400 WEST OLYMPIC BLVD. SUITE 200 LOS ANGELES CA 90064 (888) 958-1084
Immix Biopharma, Inc. (Filer) CIK: 0001873835 (see all company filings)

EIN.: 454869378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-277163 | Film No.: 24650029
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)